Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
MASLD and MASH can lead to liver fibrosis, cirrhosis and liver cancer.
An increase in fatty liver disease could double liver cancer cases and nearly triple the need for transplants by 2050.
Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.
Egypt has diagnosed 87% of people living with hepatitis C and provided curative treatment for 93% of those diagnosed.
Coffee has numerous health benefits, but too much caffeine can cause problems.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.
The CDC estimates that 21% of people living with HIV also have hepatitis C virus.
Drug-related mortality, including overdose, was the leading cause of death.
About 40% of people worldwide are not aware that viral hepatitis is a leading cause of liver cancer.
Lockdowns made people feel isolated, depressed, and anxious, leading some to increase their alcohol intake.
A “jarringly low” proportion of people with HCV have been tested, treated and cured.
Study findings suggest people with chronic liver disease should be prioritized for booster shots.
The burden of viral and nonviral liver disease remains high even in the setting of hepatitis C microelimination.
People with advanced fibrosis—not just cirrhosis—were at greater risk for hepatocellular carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.